PHARMA

0.335

(%)

Quarterly rpt on consolidated results for the financial period ended 31 Mar 2020

Amended Announcements
Please refer to the earlier announcement reference number: FRA-14052020-00012

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2020
Quarter 1 Qtr
Quarterly report for the financial period ended 31 Mar 2020
The figures have not been audited

Attachments

Pharma Q1 2020.pdf
448.0 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2020

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2020
31 Mar 2019
31 Mar 2020
31 Mar 2019
$$'000
$$'000
$$'000
$$'000
1 Revenue
819,921
786,108
819,921
786,108
2 Profit/(loss) before tax
30,880
30,243
30,880
30,243
3 Profit/(loss) for the period
22,415
19,648
22,415
19,648
4 Profit/(loss) attributable to ordinary equity holders of the parent
22,399
19,617
22,399
19,617
5 Basic earnings/(loss) per share (Subunit)
8.57
7.53
8.57
7.53
6 Proposed/Declared dividend per share (Subunit)
6.00
6.00
6.00
6.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.3400
1.2900

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 19 May 2020
Category Financial Results
Reference Number FRA-19052020-00036